martedì, 5 maggio 2026

Notizie AIOM – anno XV

FDA Grants Entrectinib Breakthrough Designation for NTRK+ Solid Tumors

May 16, 2017 - The FDA has granted a breakthrough therapy designation to entrectinib for use as a treatment for adult and pediatric patients with NTRK-positive, locally advanced or metastatic solid tumors who have either progressed following prior therapies or who have no ...
Leggi tutto

FDA Grants Priority Review to Copanlisib for Follicular Lymphoma

May 17, 2017 - The FDA has granted a priority review designation to copanlisib as a treatment for patients with relapsed/refractory follicular lymphoma who have received at 2 least prior therapies, according to Bayer, the manufacturer of the PI3K dual-isoform inhibitor. ...
Leggi tutto

The Addition of Adjuvant Chemotherapy to Radiation in Early-Stage High-Risk Endometrial Cancer: Survival Outcomes and Patterns of Care

Early-stage high-risk endometrial cancer (HREC) treated with adjuvant radiotherapy (aRT) alone has been associated with an increased risk of distant relapse. The addition of chemotherapy to radiotherapy (aCRT) may benefit overall survival (OS). We investigated the patterns-of-care ...
Leggi tutto

Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials

Research has shown that a greater adherence to the Mediterranean diet is associated with a reduced risk of major chronic disease. However, the existing literature leads to debate for different issues, such as the measurement of the adherence to the Mediterranean diet, the ...
Leggi tutto

18 maggio 2017 – Pubblicazione per Procedura budget 2016 (Articolo 21 DL 113/2016)

FDA Approves Pembrolizumab for Urothelial Carcinoma

May 18, 2017 - The FDA approved pembrolizumab for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy or within 12 months of neoadjuvant or adjuvant treatment ...
Leggi tutto

15 maggio 2017 – Approccio comportamentale per la prescrizione appropriata di antimicrobici in ospedale

15 maggio 2017 – Comunicazione AIFA agli Assessorati alla Sanità delle Regioni

16 maggio 2017 – Procedura per le domande di variazione e rinnovo di prodotti dove l’Italia agisce da Stato Membro di Riferimento (RMS)

17 maggio 2017 – EMA. Pubblicato l’Annual Report 2016